Infliximab Efficacy, TDM and Serum TNFα Levels in Pediatric HSCT Recipients With aGVHD: Prospective Observational Study

CompletedOBSERVATIONAL
Enrollment

28

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

February 28, 2023

Study Completion Date

May 31, 2025

Conditions
Graft Versus Host Disease, AcuteHematopoietic Stem Cell Transplantation
Trial Locations (1)

37137

IRCCS Burlo Garofolo, Trieste

All Listed Sponsors
lead

University of Pisa

OTHER